Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Privia Health Group Inc shares valued at $225,074 were sold by Mehrotra Parth on Apr 30 ’24. At $18.42 per share, Mehrotra Parth sold 12,219 shares. The insider’s holdings dropped to 261,640 shares worth approximately $4.82 million following the completion of this transaction.
Also, Morris Matthew Shawn sold 11,059 shares, netting a total of over 203,707 in proceeds. Following the sale of shares at $18.42 each, the insider now holds 70,101 shares.
Before that, Mountcastle David had sold 2,320 shares from its account. In a trade valued at $42,734, the EVP & Chief Financial Officer traded Privia Health Group Inc shares for $18.42 each. Upon closing the transaction, the insider’s holdings decreased to 2,320 shares, worth approximately $4.79 million.
As published in their initiating research note from Citigroup on April 22, 2024, Privia Health Group Inc [PRVA] has been a Buy and the price target has been revised to $25. Analysts at Barclays started covering the stock with ‘”an Equal weight”‘ outlook in a report released in early March. Earlier on February 22, 2024, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for PRVA stock which previously was a “a Buy”.
Analyzing PRVA Stock Performance
During the last five days, there has been a surge of approximately 2.33%. Over the course of the year, Privia Health Group Inc shares have dropped approximately -20.06%. Shares of the company reached a 52-week high of $24.05 on 01/02/24 and a 52-week low of $17.54 on 04/02/24. A 50-day SMA is recorded $19.64, while a 200-day SMA reached $22.29. Nevertheless, trading volume fell to 0.78 million shares from 0.64 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 18.04, which, if violated, would cause prices to drop to 17.66. In the upper region, resistance lies at 18.69. The next price resistance is at 18.96. RSI (Relative Strength Index) is 47.12 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 41.78%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
